1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThe 2035 Fund is designed to strengthen every layer of the life sciences ecosystem, spanning startups, research labs, industry leaders, and the next generation of life sciences talent in Massachusetts.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Startups, research labs, industry leaders, and life sciences talent within the Massachusetts life sciences ecosystem. Confirm the full requirements in the official notice before applying.
The 2035 Fund is funded by Massachusetts Life Sciences Center. Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Ralph C. Wilson, Jr. Foundation Grant is a grant program from the Ralph C. Wilson, Jr. Foundation that funds nonprofit organizations working within the Foundation's focus areas in Southeast Michigan, with a sustained investment commitment through 2035. Focus areas include Youth Sports & Recreation, Parks Trails & Green Design, Caregiving, and Preparing for Success initiatives that build workforce readiness and long-term opportunity. The Foundation partners with nonprofits that share its mission to expand long-term, equitable opportunity across Southeast Michigan communities. Eligible applicants are nonprofit organizations whose programs align with one of the Foundation's stated focus areas and demonstrate measurable impact for residents of Southeast Michigan.
NSW Innovation Blueprint 2035 - Innovative Manufacturing Adoption Fund is sponsored by Investment NSW (NSW Government). The NSW Innovation Blueprint 2035 includes funding for initiatives to support manufacturing businesses in adopting innovative technologies. This aligns with broader goals to advance innovation in NSW and promote economic growth and job creation.
The U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articleAwards slashed by half, life sciences applicants rejected at 95%, and the White House steering which fields get funded. How the GRFP went from funding the person to funding the priority.
Read articleAfter a rare gap with zero active omnibus NOFOs, NIH has reissued its SBIR/STTR parent announcements — collapsing four solicitations into two, adding a Strategic Breakthrough bridge and a Commercialization Readiness Pilot, and reopening the funnel with a September 5, 2026 receipt date. Here are the exact solicitation numbers, the new budget ceilings, what actually changed, and how a small business should sequence its submission.
Read article